Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
suvorexant (belsomra) (1 trial)
Sleep Initiation and Maintenance Disorders (Phase 4)
Trials (1 total)
Trial APIs (1 total)